Skip to content

Antibody to SARS-CoV-2 Nucleocapsid Protein (Serum)

Published: August 9, 2026Updated: August 16, 2026

This test checks for antibodies in your blood that your immune system produces in response to the SARS-CoV-2 virus, which causes COVID-19. Antibodies can help your body recognize and fight past infections.

Quick summary

["This test helps track your immune response to COVID-19, often used for monitoring recovery or assessing past infection status."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
27147-8
Short code
Deprecated S pneum19 Ab sp2 Ser-mCnc
Synonyms
Deprecated S pneum19 Ab sp2 Ser-mCnc
Category
coagulation
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may order this test if you’ve had symptoms of COVID-19 or been exposed to the virus. It can also be used in research or screening studies to detect antibodies after infection, even if you no longer test positive for the virus itself.

What to Expect Before the Test

No special preparation is needed. You’ll likely have a simple blood draw from a vein in your arm. The test is usually done in a lab and results may take a few days to weeks, depending on your healthcare provider’s process.

What the Results Mean

Positive results indicate the presence of antibodies against the nucleocapsid protein, suggesting you’ve likely been infected with SARS-CoV-2 at some point. Negative results mean no detectable antibodies were found, which could mean you haven’t been infected recently or haven’t developed antibodies yet.

Common Uses of This Test

This test is primarily used for research, public health surveillance, or in studies focused on understanding immunity to COVID-19. It’s not typically used for diagnosing active COVID-19 infection, as it relies on detecting past exposure rather than current infection.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

COVID-19 Nucleocapsid Antibody Test

Frequently asked questions

When Might I Get This Test?
This test is often part of larger studies, research projects, or screening programs, especially if you’ve had COVID-19 symptoms or exposure. Your healthcare provider or research team will explain the purpose and timing of the test.
What Does a Positive Result Mean for Me?
A positive result means your body has made antibodies against the virus, which suggests you’ve likely been infected with COVID-19 at some point. This doesn’t mean you’re currently infected, but it can help track immunity or exposure in research settings.
Can This Test Be Used to Confirm a Past COVID-19 Infection?
Yes, in research or specific screening contexts, this test can help confirm past infection by detecting antibodies. However, it’s not a standard diagnostic tool for active COVID-19 cases and should be used alongside other tests or clinical judgment.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy